ReviewGenes & development2026
Structure, function, regulation, evolution, and therapeutic implications of PARP14.
Review in Genes & development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular Target Discovery and Systemic Mechanism Analysis of Teriflunomide for Dry Eye Disease.Current issues in molecular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
ADP-ribosylation (ADPr) is a posttranslational modification conserved across all domains of life that regulates a wide variety of processes. Among ADP-ribosyl transferases (ARTs) in humans, PARP14 has emerged as a key regulator involved in antiviral defense, inflammation, and DNA damage response. Recent studies have uncovered its dynamic and versatile roles in modulating DNA replication stress and DNA repair, positioning it at the intersection of genomic stability and immune regulation. Despite growing insights into its molecular functions, many aspects of PARP14-mediated signaling remain elusive. In this perspective, we explore the fundamental and emerging biological features of PARP14, highlighting its structure, function, evolution, and roles in cellular homeostasis and disease. Additionally, we discuss recent advances in targeting PARP14 for therapeutic intervention, particularly in oncology and immunology. A deeper mechanistic understanding of PARP14 function may inform the development of novel therapeutic strategies that exploit its regulatory network for clinical benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.